Search research articles
Contact Us
Filters
Showing results (21-30 of 44) with videos related to
Page
of 5
Sort By:
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)
|
August 30, 2017
The Effect of Alpha-1 Proteinase Inhibitor on Biomarkers of Elastin Degradation in Alpha-1 Antitrypsin Deficiency: An Analysis of the RAPID/RAPID Extension Trials
Shuren Ma, Yong Y Lin, Jerome O Cantor, et al.
The New England Journal of Medicine
|
October 13, 2021
Efficacy of a Cell-Culture-Derived Quadrivalent Influenza Vaccine in Children
Terence Nolan, Alexandre C Fortanier, Brett Leav, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
|
January 31, 2006
Efficacy of montelukast during the allergy season in patients with chronic asthma and seasonal aeroallergen sensitivity
William W Busse, Thomas B Casale, Mark S Dykewicz, et al.
Circulation. Arrhythmia and Electrophysiology
|
October 8, 2009
Incidence of atrial fibrillation in relation to changing heart rate over time in hypertensive patients: the LIFE study
Peter M Okin, Kristian Wachtell, Sverre E Kjeldsen, et al.
Circulation
|
July 30, 2003
Regression of electrocardiographic left ventricular hypertrophy by losartan versus atenolol: The Losartan Intervention for Endpoint reduction in Hypertension (LIFE) Study
Peter M Okin, Richard B Devereux, Sverker Jern, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
|
August 3, 2010
The Back to School asthma study: the effect of montelukast on asthma burden when initiated prophylactically at the start of the school year
Kevin B Weiss, James E Gern, Neil W Johnston, et al.
Circulation
|
March 15, 2006
Impact of diabetes mellitus on regression of electrocardiographic left ventricular hypertrophy and the prediction of outcome during antihypertensive therapy: the Losartan Intervention For Endpoint (LIFE) Reduction in Hypertension Study
Peter M Okin, Richard B Devereux, Eva Gerdts, et al.
Lancet (London, England)
|
June 1, 2015
Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial
Kenneth R Chapman, Jonathan G W Burdon, Eeva Piitulainen, et al.
Journal of the Peripheral Nervous System : JPNS
|
June 9, 2017
Minimum clinically important difference analysis confirms the efficacy of IgPro10 in CIDP: the PRIMA trial
Ingemar S J Merkies, John-Philip Lawo, Jonathan M Edelman, et al.
British Journal of Clinical Pharmacology
|
June 30, 2017
Quantitative disease progression model of α-1 proteinase inhibitor therapy on computed tomography lung density in patients with α-1 antitrypsin deficiency
Michael A Tortorici, James A Rogers, Oliver Vit, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 44) with videos related to
Sort By:
Page
of 5
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)
|
August 30, 2017
The Effect of Alpha-1 Proteinase Inhibitor on Biomarkers of Elastin Degradation in Alpha-1 Antitrypsin Deficiency: An Analysis of the RAPID/RAPID Extension Trials
Shuren Ma, Yong Y Lin, Jerome O Cantor, et al.
The New England Journal of Medicine
|
October 13, 2021
Efficacy of a Cell-Culture-Derived Quadrivalent Influenza Vaccine in Children
Terence Nolan, Alexandre C Fortanier, Brett Leav, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
|
January 31, 2006
Efficacy of montelukast during the allergy season in patients with chronic asthma and seasonal aeroallergen sensitivity
William W Busse, Thomas B Casale, Mark S Dykewicz, et al.
Circulation. Arrhythmia and Electrophysiology
|
October 8, 2009
Incidence of atrial fibrillation in relation to changing heart rate over time in hypertensive patients: the LIFE study
Peter M Okin, Kristian Wachtell, Sverre E Kjeldsen, et al.
Circulation
|
July 30, 2003
Regression of electrocardiographic left ventricular hypertrophy by losartan versus atenolol: The Losartan Intervention for Endpoint reduction in Hypertension (LIFE) Study
Peter M Okin, Richard B Devereux, Sverker Jern, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
|
August 3, 2010
The Back to School asthma study: the effect of montelukast on asthma burden when initiated prophylactically at the start of the school year
Kevin B Weiss, James E Gern, Neil W Johnston, et al.
Circulation
|
March 15, 2006
Impact of diabetes mellitus on regression of electrocardiographic left ventricular hypertrophy and the prediction of outcome during antihypertensive therapy: the Losartan Intervention For Endpoint (LIFE) Reduction in Hypertension Study
Peter M Okin, Richard B Devereux, Eva Gerdts, et al.
Lancet (London, England)
|
June 1, 2015
Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial
Kenneth R Chapman, Jonathan G W Burdon, Eeva Piitulainen, et al.
Journal of the Peripheral Nervous System : JPNS
|
June 9, 2017
Minimum clinically important difference analysis confirms the efficacy of IgPro10 in CIDP: the PRIMA trial
Ingemar S J Merkies, John-Philip Lawo, Jonathan M Edelman, et al.
British Journal of Clinical Pharmacology
|
June 30, 2017
Quantitative disease progression model of α-1 proteinase inhibitor therapy on computed tomography lung density in patients with α-1 antitrypsin deficiency
Michael A Tortorici, James A Rogers, Oliver Vit, et al.
Page
of 5